Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

D-Wave Quantum's promising growth is tempered by high valuations and market risks. Learn why QBTS stock is now rated Hold ...

Edward Kellman, CEO and chief design engineer of Trakker Apps, holds two U.S. patents for an innovative take on double-entry ...

Ubisoft CEO Yves Guillemot and human resources director Marie Derain will be summoned to court to testify in the trial ...

Q1 2025 Earnings Call Transcript May 27, 2025 BioLineRx Ltd. beats earnings expectations. Reported EPS is $1.39, expectations ...

We love linen for its natural temperature-regulating properties and durability. The best linen sheets include soft, cooling, ...

ASX health stocks have had a strong week with a wave of capital raisings in the sector as firms seek to strengthen their balance sheets.

Teos Therapeutics, Inc. (NASDAQ:ITOS) reported topline results from an updated interim analysis of the GALAXIES Lung-201 Phase 2 study on Tuesday. The trial sponsored by GSK Plc (NYSE:GSK) assessed ...

Elon Musk is criticizing President Donald Trump’s “big, beautiful bill,” exposing a significant fracture in a partnership ...

"The mining companies were forced to abandon all activities immediately, and make good any initial damage ... Nevertheless, ...

Boeing (BA 0.23%) stock is up around 14% so far this year, and analysts have been raising their price targets after the company reported a narrower-than-expected first-quarter los ...